
New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA

The proposal seeks to move any future LDT authority away from the FDA

Consultant Nora Hess offers suggestions for clinical labs to navigate these problems

Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA

But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort

Laboratories must register for email-only communications and submit all CLIA fees electronically